C8 GBI Good Governance November 2021 Monthly Report – Cirdan Capital


The certificate fell by 1% on the month.  The Good Governance premia had been making steady gains before falling, towards the end of the month, as volatility returned to US stocks (the certificate is already back higher in early December).

Looking at the performance of the underlying equities, Tech continues to perform well with Nvidia, HP and Apple the headline outperformers. There was underperformance in Healthcare, as Merck and Waters lost ground after last month’s sharp rise, whilst potential lawsuits against Activision have knocked that stock.

Overall positioning is unchanged in December, with a L/S of 2.25/1.85.

Other posts

C8 Weekly Bulletin: Trend Following

Central banks have had to act aggressively to contain inflation expectations - leading to an unwinding of excess global liquidity and divergent responses across asset classes.  A return to "normal" financial markets, with less policy support for asset prices and higher market volatility.  In this context, there is also new investor interest in trend-following strategies that exploit diverging market dynamics. C8 Studio contains both high quality trend-following indices and innovative combination technology. Read more →

NDR Dynamic Allocation Strategy February 2023 Update

Dynamic Allocation Strategy, indicators, weightings update Read more →

C8 Weekly Bulletin – Adding Uncorrelated Returns

With equity and bond markets having moved in tandem for the past few years, this week's Bulletin focuses on the potential to add uncorrelated returns to an equity/bond portfolio.   Read more →
Back to all posts →